|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 12 of 12
Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | article | Hosoda, Shunichi; Suda, Goki; Sho, Takuya; Ogawa, Koji; Kimura, Megumi; Yang, Zijian; Yoshida, Sonoe; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Miyagishima, Takuto; Sakamoto, Naoya | Low baseline CXCL9 predicts early progressive disease in unresectable HCC with atezolizumab plus bevacizumab treatment | - | Liver Cancer | - | Jun-2023 |
article | Sho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, Naoya | Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150 | - | Cancers | - | 15-Aug-2022 |
article | Takimoto-Sato, Michiko; Miyauchi, Toshinari; Suzuki, Masaru; Ujiie, Hideyuki; Nomura, Toshifumi; Ikari, Tomoo; Nakamura, Tomohiko; Takahashi, Kei; Matsumoto-Sasaki, Machiko; Kimura, Hirokazu; Kimura, Hiroki; Matsui, Yuichiro; Kitagataya, Takashi; Yamada, Ren; Suzuki, Kazuharu; Nakamura, Akihisa; Nakai, Masato; Sho, Takuya; Ogawa, Koji; Sakamoto, Naoya; Yamaguchi, Naoko; Otsuka, Noriyuki; Tomaru, Utano; Konno, Satoshi | Case Report : Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia | - | Frontiers in Genetics | - | May-2022 |
article | Nakai, Masato; Yamamoto, Yoshiya; Baba, Masaru; Suda, Goki; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Sho, Takuya; Morikawa, Kenichi; Ogawa, Koji; Furuya, Ken; Sakamoto, Naoya | Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication | - | Scientific reports | - | 27-Jan-2022 |
article | Shigesawa, Taku; Suda, Goki; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma | - | JGH open | - | Oct-2020 |
article (author version) | Kitagataya, Takashi; Suda, Goki; Nagashima, Kazunori; Katsurada, Takehiko; Yamamoto, Koji; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Komatsu, Yoshito; Hata, Hiroo; Takeuchi, Satoshi; Abe, Takashige; Sakakibara-Konishi, Jun; Teshima, Takanori; Homma, Akihiro; Sakamoto, Naoya | Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan | - | Journal of gastroenterology and hepatology | - | Oct-2020 |
article (author version) | Kawagishi, Naoki; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Shimazaki, Tomoe; Yamada, Ren; Kitagataya, Takashi; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Sakamoto, Naoya | High serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C | - | Hepatology Research | - | Jun-2020 |
article | Sho, Takuya; Suda, Goki; Ogawa, Koji; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Kobayashi, Tomoe; Meguro, Takashi; Saga, Akiyoshi; Miyagishima, Takuto; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Sakamoto, Naoya | Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting | - | JGH open | - | Feb-2020 |
article | Ogawa, Koji; Kobayashi, Takashi; Furukawa, Jun-ichi; Hanamatsu, Hisatoshi; Nakamura, Akihisa; Suzuki, Kazuharu; Kawagishi, Naoki; Ohara, Masatsugu; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Baba, Masaru; Furuya, Ken; Terashita, Katsumi; Kobayashi, Tomoe; Onodera, Manabu; Horimoto, Takahiro; Shinada, Keisuke; Tsunematsu, Seiji; Tsunematsu, Izumi; Meguro, Takashi; Mitsuhashi, Tomoko; Hato, Megumi; Higashino, Kenichi; Shinohara, Yasuro; Sakamoto, Naoya | Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis : a novel glycobiomarker for non-alcoholic steatohepatitis | - | Scientific reports | - | 15-Jan-2020 |
article | Suda, Goki; Nakai, Masato; Sho, Takuya; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Baba, Masaru; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment | - | Internal medicine | - | 1-Apr-2019 |
article | Ohara, Masatsugu; Ogawa, Koji; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Shimazaki, Tomoe; Suzuki, Kazuharu; Nakamura, Akihisa; Umemura, Machiko; Izumi, Takaaki; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ohnishi, Shunsuke; Sakamoto, Naoya | L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis | - | Hepatology communications | - | Aug-2018 |
article | Kawagishi, Naoki; Suda, Goki; Nakamura, Akinobu; Kimura, Megumi; Maehara, Osamu; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Izumi, Takaaki; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Miyoshi, Hideaki; Sakamoto, Naoya | Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis | - | PLOS ONE | - | 2018 |
Showing results 1 to 12 of 12
|